Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Antiviral therapy (London)")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1547

  • Page / 62
Export

Selection :

  • and

A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?RAMOS-ESTEBANEZ, Ciro; LIZARRAGA, Karlo J; MERENDA, Amedeo et al.Antiviral therapy (London). 2014, Vol 19, Num 2, pp 133-139, issn 1359-6535, 7 p.Article

Sodium tanshinone IIA sulfonate inhibits porcine reproductive and respiratory syndrome virus via suppressing N gene expression and blocking virus-induced apoptosisNA SUN; LI, E; ZHIWEI WANG et al.Antiviral therapy (London). 2014, Vol 19, Num 1, pp 89-95, issn 1359-6535, 7 p.Article

Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761)MARGOLIS, David A; ERON, Joseph J; DEJESUS, Edwin et al.Antiviral therapy (London). 2014, Vol 19, Num 1, pp 69-78, issn 1359-6535, 10 p.Article

An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional studyKOETHE, John R; AIHUA BIAN; SHINTANI, Ayumi K et al.Antiviral therapy (London). 2013, Vol 18, Num 5, pp 729-733, issn 1359-6535, 5 p.Article

Andes―virus―induced cytokine storm is partially suppressed by ribavirinKHAIBOULLINA, Svetlana F; RIZVANOV, Albert A; LOMBARDI, Vincent C et al.Antiviral therapy (London). 2013, Vol 18, Num 4, pp 575-584, issn 1359-6535, 10 p.Article

Decreasing rate of multiple treatment modifications among individuals who initiated antiretroviral therapy in 1997―2009 in the Danish HIV Cohort StudyHELLEBERG, Marie; KRONBORG, Gitte; LARSEN, Carsten S et al.Antiviral therapy (London). 2013, Vol 18, Num 3, pp 345-354, issn 1359-6535, 10 p.Article

Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysisIONNAZZO, Sergio; COCO, Barbara; BRUNETTO, Maurizia R et al.Antiviral therapy (London). 2013, Vol 18, Num 4, pp 623-633, issn 1359-6535, 11 p.Article

Ongoing HIV replication in cerebrospinal fluid under successful monotherapyBIERHOFF, Marieke; BOUCHER, Charles A. B; FIBRIANI, Azzania et al.Antiviral therapy (London). 2013, Vol 18, Num 4, pp 641-643, issn 1359-6535, 3 p.Article

Rates of emergence of HIV drug resistance in resource―limited settings: a systematic reviewSTADELI, Kathryn M; RICHMAN, Douglas D.Antiviral therapy (London). 2013, Vol 18, Num 1, pp 115-123, issn 1359-6535, 9 p.Article

Review of drug interactions with telaprevir and antiretroviralsVAN HEESWIJK, Rolf P. G; BEUMONT, Maria; KAUFFMAN, Robert S et al.Antiviral therapy (London). 2013, Vol 18, Num 4, pp 553-560, issn 1359-6535, 8 p.Article

Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistanceTSENG, Alice L; LA PORTE, Charles; SALIT, Irving E et al.Antiviral therapy (London). 2013, Vol 18, Num 5, pp 735-738, issn 1359-6535, 4 p.Article

Targeting human papillomavirus genome replication for antiviral drug discoveryARCHAMBAULT, Jacques; MELENDY, Thomas.Antiviral therapy (London). 2013, Vol 18, Num 3, pp 271-283, issn 1359-6535, 13 p.Article

Time patterns of adherence and long―term virological response to non―nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ ESTHER trial in CameroonMERESSE, Mégane; PATRIZIA CARRIERI, Maria; MOATTI, Jean-Paul et al.Antiviral therapy (London). 2013, Vol 18, Num 1, pp 29-37, issn 1359-6535, 9 p.Article

Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevirBENITO, José M; SÁNCHEZ-PARRA, Clara; MAIDA, Ivana et al.Antiviral therapy (London). 2013, Vol 18, Num 5, pp 709-715, issn 1359-6535, 7 p.Article

Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovirTAKKENBERG, R. Bart; JANSEN, Louis; RIJCKBORST, Vincent et al.Antiviral therapy (London). 2013, Vol 18, Num 7, pp 895-904, issn 1359-6535, 10 p.Article

HIV-1 drug resistance in treatment-naive, chronically infected patients in JamaicaBARROW, Geoffrey J; HYLTON-KONG, Tina; RODRIGUEZ, Nayra et al.Antiviral therapy (London). 2013, Vol 18, Num 7, pp 941-944, issn 1359-6535, 4 p.Article

Pharmacokinetics and safety in cynomolgus monkeys of a monoclonal antibody targeting human scavenger receptor class B type-1 for hepatitis C treatmentFLORES, M. Victoria; CORBAU, Romuald G; GUIONAUD, Silvia et al.Antiviral therapy (London). 2013, Vol 18, Num 6, pp 775-784, issn 1359-6535, 10 p.Article

Exploring the story of women living with HIV in EuropeAntiviral therapy (London). 2013, Vol 18, issn 1359-6535, 55 p., SUP2Serial Issue

The need for data on women living with HIV in EuropeHABERL, Annette; JOHNSON, Margaret; DOMINGUEZ, Stephanie et al.Antiviral therapy (London). 2013, Vol 18, pp 1-10, issn 1359-6535, 10 p., SUP2Article

Genetic diversity of HCV in BrazilLAMPE, Elisabeth; LEWIS-XIMENEZ, Lia; GERMANO, Fabiana N et al.Antiviral therapy (London). 2013, Vol 18, Num 3, pp 435-444, issn 1359-6535, 10 p., bConference Paper

Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patientsHUANG, Yi-Wen; HU, Jui-Ting; HU, Fu-Chang et al.Antiviral therapy (London). 2013, Vol 18, Num 4, pp 567-573, issn 1359-6535, 7 p.Article

A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipientsHU, Tsung-Hui; TSAI, Ming-Chao; CHIEN, Yu-Shu et al.Antiviral therapy (London). 2012, Vol 17, Num 4, pp 745-753, issn 1359-6535, 9 p.Article

Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysisKUROSAKI, Masayuki; HIRAMATSU, Naoki; NAKAGAWA, Mina et al.Antiviral therapy (London). 2012, Vol 17, Num 1, pp 35-43, issn 1359-6535, 9 p.Article

Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro4'-azidocytidine, against human and duck HBV replicationLIYUN ZHENG; OIANG WANG; QINGDUAN WANG et al.Antiviral therapy (London). 2012, Vol 17, Num 4, pp 679-687, issn 1359-6535, 9 p.Article

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfectionWORODRIA, William; MENTEN, Joris; COLEBUNDERS, Robert et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 841-848, issn 1359-6535, 8 p.Article

  • Page / 62